Commentary
Enhancement drugs: are there limits to what we should enhance and why?
-
Correspondence: Morten Hesse mh@crf.au.dk
BMC Medicine 2010, 8:50 doi:10.1186/1741-7015-8-50
No comments have yet been made on this article.